The role of Circulating Tumor Cells (CTCs) in Predicting the Response of Primary (Neoadjuvant) Chemotherapy and its Impact as a Prognostic Factor in Early Breast

Research Authors
Zedan A,Zahran AM,Maximos DW, Hassan MFS
Research Department
Department of Medical Oncology
Research Journal
SECI Oncology,,,,2014
Research Member
Ashraf Zeidan Abdalla Ahmed
Research Rank
1
Research Year
2014

Increased susceptibility to apoptosis and growth arrest of human breast cancer cells treated by a snake venom-loaded silica nanoparticles

Research Authors
Badr G, Sayed D, Maximous D, Mohamed AO, Gul M.
Research Department
Department of Surgical Oncology
Research Journal
Cell Physiol Biochem.
Research Member
Doaa Wadie Maximous Dawoud
Research Pages
1640-51
Research Rank
1
Research Year
2014

Feasibility of breast conservation after neoadjuvant taxene based chemotherapy in locally advanced breast cancer: a Prospective Phase I trial

Research Abstract
Neoadjuvant chemotherapy is the standard care for locally advanced breast cancer. Our study aimed at evaluating the feasibility of breast conversation surgery (BCS) after neoadjuvant chemotherapy. Patients and methods: Forty five patients had stage IIB (except those with T2N1 disease) and stage IIIA were selected to 3 cycles taxane-based neoadjuvant chemotherapy. Patient who had tumours≤ 5 cm underwent a tentative BCS while patients who had tumour size> 5 cm underwent radical surgery. Negative margin is .
Research Authors
Mohamed I El-Sayed, Doaa W Maximous, Mohamed A Aboziada, Mostafa E Abdel-Wanis, Nabiel NH Mikhail
Research Department
Department of Radiotherapy and Nuclear medicine
Research Journal
Ann Surg Innov Res
Research Member
Mohamed Ibrahim Mohamed El-Sayed
Research Rank
1
Research Year
2010

Feasibility of breast conservation after neoadjuvant taxene based chemotherapy in locally advanced breast cancer: a Prospective Phase I trial

Research Abstract
Neoadjuvant chemotherapy is the standard care for locally advanced breast cancer. Our study aimed at evaluating the feasibility of breast conversation surgery (BCS) after neoadjuvant chemotherapy. Patients and methods: Forty five patients had stage IIB (except those with T2N1 disease) and stage IIIA were selected to 3 cycles taxane-based neoadjuvant chemotherapy. Patient who had tumours≤ 5 cm underwent a tentative BCS while patients who had tumour size> 5 cm underwent radical surgery. Negative margin is .
Research Authors
Mohamed I El-Sayed, Doaa W Maximous, Mohamed A Aboziada, Mostafa E Abdel-Wanis, Nabiel NH Mikhail
Research Department
Department of Surgical Oncology
Research Journal
Ann Surg Innov Res
Research Member
Doaa Wadie Maximous Dawoud
Research Rank
1
Research Year
2010
Subscribe to